Ventyx Biosciences Inc (NASDAQ: VTYX) on Friday, plunged -6.07% from the previous trading day, before settling in for the closing price of $2.8. Within the past 52 weeks, VTYX’s price has moved between $0.78 and $3.39.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -87.13% annually for the last half of the decade. The company achieved an average annual earnings per share of 4.21%. With a float of $63.06 million, this company’s outstanding shares have now reached $71.16 million.
In an organization with 82 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Ventyx Biosciences Inc (VTYX) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Ventyx Biosciences Inc is 11.38%, while institutional ownership is 68.72%. The most recent insider transaction that took place on Apr 02 ’25, was worth 2,019. In this transaction CHIEF SCIENTIFIC OFFICER of this company sold 1,887 shares at a rate of $1.07, taking the stock ownership to the 467,226 shares. Before that another transaction happened on Dec 27 ’24, when Company’s CHIEF SCIENTIFIC OFFICER sold 21,119 for $2.36, making the entire transaction worth $49,841. This insider now owns 464,582 shares in total.
Ventyx Biosciences Inc (VTYX) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 4.21% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -3.15% during the next five years compared to -87.13% drop over the previous five years of trading.
Ventyx Biosciences Inc (NASDAQ: VTYX) Trading Performance Indicators
Ventyx Biosciences Inc (VTYX) is currently performing well based on its current performance indicators. A quick ratio of 19.57 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.75, a number that is poised to hit -0.47 in the next quarter and is forecasted to reach -2.07 in one year’s time.
Technical Analysis of Ventyx Biosciences Inc (VTYX)
Let’s dig in a bit further. During the last 5-days, its volume was 1.04 million. That was inferior than the volume of 1.44 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 11.97%.
During the past 100 days, Ventyx Biosciences Inc’s (VTYX) raw stochastic average was set at 71.95%, which indicates a significant increase from 2.04% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.23 in the past 14 days, which was higher than the 0.16 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.44, while its 200-day Moving Average is $1.96. However, in the short run, Ventyx Biosciences Inc’s stock first resistance to watch stands at $2.74. Second resistance stands at $2.84. The third major resistance level sits at $2.90. If the price goes on to break the first support level at $2.57, it is likely to go to the next support level at $2.51. Assuming the price breaks the second support level, the third support level stands at $2.41.
Ventyx Biosciences Inc (NASDAQ: VTYX) Key Stats
Market capitalization of the company is 187.15 million based on 71,161K outstanding shares. Right now, sales total 0 K and income totals -135,120 K. The company made 0 K in profit during its latest quarter, and -27,440 K in sales during its previous quarter.
